etrozole in symptomatic uterine fibroids
Phase 2
Recruiting
- Conditions
- Symptomatic Uterine Fibroids.Abnormal uterine and vaginal bleeding, unspecifiedN93.9
- Registration Number
- IRCT20221108056446N10
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Women with symptomatic uterine fibroids
Abnormal uterine bleeding
Exclusion Criteria
pregnancy
Other uterine diseases such as malignancy
Hormonal disorders
Taking other drugs for the treatment of uterine fibroids
The occurrence of unwanted side effects of drugs
Deterioration of patients during the treatment period
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method